Chemiluminescent Labeled Organic Reagents and Their Use in Analysis of Organic Compounds by Hummelen, Jan C. & Wynberg, Hans
  
 University of Groningen
Chemiluminescent Labeled Organic Reagents and Their Use in Analysis of Organic
Compounds
Hummelen, Jan C.; Wynberg, Hans
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
1990
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Hummelen, J. C., & Wynberg, H. (1990). Chemiluminescent Labeled Organic Reagents and Their Use in
Analysis of Organic Compounds.
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
United States Patent[19] [11] Patent Number: 4,975,380
Hummelen et al. [45] Date of Patent: Dec. 4, 1990
[54] CHEMILUMINESCENT LABELED ORGANIC
REAGENTS AND THEIR USE IN ANALYSIS
OF ORGANIC COMPOUNDS
[75] Inventors: Jan C. Hummelen, Groningen; Hans
Wynberg, Haren, both of
Netherlands
[73] Assignee: Rijksuniversiteit Te Groningen,
Groningen, Netherlands
[21] Appl. No.: 445,147
[22] Filed: Nov. 30, 1989
Related U.S. Application Data
[63] Continuation of Ser. No. 285,360, Dec. 14, 1988, aban-
doned, which is a continuation of Ser. No. 845,129,
Dec. 9, 1985, abandoned.
[30] Foreign Application Priority Data
Apr. 16, 1984 [NL] Netherlands ........................... 8401213
[51] Int. Cl.5 ............................... C07D 209/38; C07D 209/46;
C07D 303/00; G01N 33/533
[52] U.S. Cl. .......................................... 436/546; 436/536;
436/800; 548/513; 549/332




 WO83/0360410/1983 PCT Int'l Appl. .
Primary Examiner-Christine Nucker
Assistant Examiner-Karen I. Krupen
Attorney, Agent, or Firm-William M. Blackstone
[57] ABSTRACT
Thermochemically induced luminescence is generated
in a fluorescent labeled organic compound containing a
covalently bonded fluorescent label which is a polycy-
clic aromatic radical having at least three linearly fused
benzene rings and capable of being excited to a fluores-
cent electronic excited state by energy transfer from an
energy donor molecule or radical having an electronic
excited state, by a process comprising generating an
energy donor radical or molecule by a thermochemical
reaction in the presence of the fluorescent label. The
energy donor radical may be generated by a chemical
reaction in the presence of the fluorescent labeled or-
ganic compound or the fluorescent labeled compound
itself may be additionally labeled with a radical capable
of being excited to an electronic excited state by a ther-
mochemical reaction, i.e., by a process initiated by ad-
sorption of thermal energy.

















REAGENTS AND THEIR USE IN ANALYSIS OF
ORGANIC COMPOUNDS
This is a continuation of application Ser. No.
07,285,360 filed Dec. 14, 1988, abandoned, which is a
continuation of application Ser. No. 06,845,129 filed
Dec. 9, 1985, abandoned.
FIELD OF THE INVENTION
1. Background of the Invention
This invention relates to organic compounds bearing a
luminescent label and more particularly to chemilumi-
nescent labeled organic reagents.
2. Description of the Prior Art
Organic analysis, particularly immunoanalysis, using
labeled reagents having a luminescent label has for some
time been a useful analytical technique. In practicing this
method of analysis a labeled reagent bearing a lumi-
nescent, i.e., fluorescent or phosphorescent, label is
reacted with an analyte to form a labeled complex. After
separation of the complex from the unreacted reagents,
the analyte is quantitated by stimulating the label to
luminescence, usually by irradiation with light of an
appropriate wavelength which when absorbed by the
label excited it to a fluorescent or phosphorescent excited
state from which it returns to the ground state with
emission of detectable radiation. This method of analysis
is sensitive and convenient, but it requires the availability
of a source of exciting light with which to excite the
luminescence of the label.
It is also known to label an organic reagent with a
chemiluminescent label which can be excited to a lumi-
nescent state by reaction with an added reagent. This
procedure does not require a source of exciting light and
it offers the possibility of less stray light reaching the
luminescence detector. However, it does require an
additional chemical step in the analytical procedure.
A further development of luminescent labeled analysis
is thermochemiluminescence, wherein the luminescence
of the label is excited by the application of heat,
ordinarily as the stimulus for a chemical reaction of the
label which forms a luminescent excited state. Such a
method is described in Dutch patent application No.
8201492, wherein organic compounds are labeled with a
2,2'-epidioxy-2,2'-adamantyladamantane radical or ana-
logue thereof, which will decompose on heating with
emission of visible light. The amount of light is propor-
tional to the amount of labeled compound present. This
method avoids the necessity for a source of exciting light
or for an additional chemical step, since the lumi-
nescence is excited simply by heating the compound to
be analyzed.
However, it has been found that the efficiency of
thermochemiluminescent analysis is rather low because
only a small fraction of the label molecules which are
excited actually return to the ground state with emission
of radiation. The great majority decay by nonradiative
processes and so not contribute to the detection of the
analyte.
Accordingly, a need has continued to exist for a
method of analysis using luminescent labeled reagents
analysis with a greater sensitivity.
SUMMARY OF THE INVENTION
It has now been found that thermochemically indu ed
luminescence having greater sensitivity can be
carried out using a fluorescent labeled organic com-
pound wherein the molecule to be labeled is bonded by
a covalent bond to a polycyclic aromatic radical having
at least three linearly fused benzene rings and capable
of being excited to a fluorescent electronic excited state
by energy transfer from an energy donor molecule or
radical having an electronic excited state. The energy
donor radical may be generated in the presence of the
fluorescent labeled organic compound or the compound
itself may be additionally labeled with a radical capable
of being excited to an electronic excited state by a
thermochemical reaction, i.e., by a process initiated by
absorption of thermal energy.
Accordingly, it is an object of the invention to pro-
vide organic reagents labeled with fluorescent labels.
A further object is to provide organic reagents having
fluorescent labels capable of being excited by energy
transf r from excited states of energy donor molecules
or radicals.
A further object is to provide organic reagents label d
with a fluorescent label and with an energy donor
radical capable of being excited to an electronic excited
state by application of heat.
Further objects of the invention will become apparent
from the description of the invention which follows.
DETAILED DESCRIPTION OF THE
INVENTION AND PREFERRED
EMBODIMENTS
The phenomenon of energy transfer from a group or
compound in a singlet and/or triplet excited state to a
compound capable of being excited to a fluorescent
state by energy transfer, is known. According to the
invention this phenomenom is used by labeling an or-
ganic compound to be assayed with apolycyclic aro-
matic radical R1, and exciting the radical R1 to a fluor-
escent state by energy transfe . The radical R1 used in
the compounds and method of this invention should be
a polycyclic aromatic radical having at least three lin-
early fused benzene rings. Suitable radicals R1 in lude
radicals derived from rubrene, perylene, 9,10'-
dibromoanthracene, 9,10-dichloroanthracene, 9,10-
diphenylanthracene, and the like. A particularly pre-
ferred radical is that derived from 9,10-diphenylanthra-
cene  The location of the polycyclic aromatic com-
pound which is covalently bonded to the labeled or-
ganic molecule is not critical.
W en the presence or the amount of an organic com-
pound labeled with one or more radicals R1 s to be
determined, the group R1 in the labeled compound is
excited to a fluorescent state and the fluorescence is
measured. This excitation can be accomplished in one
of tw  ways. In the first method a chemical reaction
which generates molecules in singlet and/or triplet
excited states is carried out in the presence of a com-
pound labeled with the radical R1. Such a reaction
might be, for example, the reaction of a suitable oxalic
acid derivative, especially of an oxalic acid ester, with
hydrogen peroxide (see Anal. Chem. 55, 432 (1983)),
or  decomposition reaction of a dioxetane.
Additional chemical reactions of this type include
enyzmatic reactions, such as, for example, the oxidation
of aliphatic and aromatic aldehydes with peroxidase. In
principle, all of the reactions yielding an energy donor,
the emission of which shows spectral overlap with the
absorption of the acceptor, are suitable.
Another way to excite the label group R1 t  a fluor-
















ganic compounds which in addition to one or more of
the R1 label groups, also contain one or more groups R2,
which can be excited to a singlet and/or triplet excited
state by thermal energy. In this case, the presence or the
amount of the so labeled compound can be determined
merely by heating the labeled compound and observing
the fluorescence. The heating leads to decomposition of
the group or groups R2 with generation of groups or
compounds in the singlet and/or triplet excited state,
which groups or compounds transfer their energy,
without radiation, to the group or groups R1. Thi will
cause the group or groups R1 to fluoresce. The emitted
fluorescence is proportional to the amount of the labeled
compound.
It will be understood by those skilled in the art that the
energy donor species may be a molecule, as when the
donor is prepared by a chemical reaction in the presence
of the fluorescent labeled energy receptor molecule, or a
radical, as when the energy donor species i  incorporated
into the fluorescent labeled compound by a covalent
bond. Thus, in this application the term energy donor
radical is used to include energy donor molecules as
well.
The so labeled organic compounds may be any or-
ganic compounds of which it is desired to determine the
presence or the amount present. More specifically the
labeled organic compounds are substances present in the
human or animal body, especially in the body fluids. As
such, proteins, steroids or fatty acids may be mentioned,
proteins being the most important.
Still more specifically, the present invention is em-
bodied in a protein labeled with one or more groups R1
and, which protein is an immunoreagent, e.g. one of an
immunologically complementary pair of reagents. Such
immunological pairs consist, for example, of antigens
and corresponding antibodies. Further, the labeled or-
ganic compound may be an immunological conjugate or
complex. If a complex contains one or more groups R1
together with one or more groups R2, R1 may be present
in one part of the complex, for example in the antibody
part, and R2 in the other part, for example in the
corresponding antigen part. Naturally, both groups R1
and R2 may also be present in a single part of the
immunological pair.
The polycyclic aromatic group R1 in the labeled
compounds according to the invention is, preferably, a
9,10-diphenylanthracyl group. This group very effi-
ciently absorbs energy from a compound in a singlet
excited state having an energy level with respect to the
ground state of more than about 70 kcal per mole. This
energy transfer excites the diphenylanthracyl group to
the excited singlet state and the group will fluoresce by
returning to the ground state. The diphenylanthracyl
group undergoes a radiative fluorescent transition to the
ground state with an efficiency of 0.9, and this figure is
practically independent of temperature.
The group R2 which is optionally present in the la-
beled organic compounds according to the invention,
preferably corresponds to formula 1,
in which A and B represent alkylene radicals which may
be connected to each other via an optional alkylene
radical C. Examples of such radicals R2 are the 2,2'-epi-
dioxy-2,2'-adamantyl-adamant-4-eq.-yl radical, the 9,9'-
pidioxy-9,9'-bicyclo[3,3,1]-nonylbicyclo[3,3,1]non-4-
eq.-yl radical, the 8,8'-epidioxy-8,8'-bicyclo[3,2,1]-oct-
2-yl or -7-yl radical, and the 10,10'-epidioxy-10,10'-bi-
cyclo[4,3,1]-decyl-bicyclo[4,3,1]-deo-2-yl or -7-yl radi-
cal. Generally, the alkylene radical A in the group of
formula 1 contains 2-5 carbon atoms, alkylene radical B
contains 2-5 carbon atoms and alkylene radical C, if
present, contains 1-4 carbon atoms. Preferably, the
group R2 in the labeled compounds according to the
invention is the 2,2'-epidioxy-2,2'-adamantyl-adamant-
4-eq.-yl radical.
As mentioned above, the invention also relates to a
process for determination or assay of an organic com-
pound labeled with one or more of the above-defined
groups R1 and, if desired, also labeled with one or more
of the above-defined groups R2, in which process the
group or groups R1 are brought to fluorescence, and the
fluorescence is measured.
The process according to the invention uses the prin-
ciple of energy transfer, as discussed above. In compari-
son with the method according to Dutch patent applica-
tion No. 8201492, in which compounds labeled exclu-
sively with groups derived from adamantyl-adamantane
dioxetane are determined or assayed, the present process
has a considerably improved sensitivity. This im-
provement in sensitivity may be understood by a con-
sideration of the fluorescence of unsubstituted adaman-
tyl-adamantane-dioxetane. Thermal decomposition of
this compound yields 2% of singlet and 15% of triplet
excited states. Return from the singlet excited state to
the ground state yields a photon of light (fluorescence)
in 1:200 cases. Return from the triplet excited state to
the ground state gives phosphorescence. The fluores-
cence efficiency of this decomposition reaction is, ac-
cordingly, 1:200 (5×10-3). According to the invention the
energy of the singlet excited state is transferred, for
example, to the 9,10-diphenyl-anthracyl radical without
emission of light. This energy transfer proceeds with an
efficiency of almost 100% if the distance between the
two molecules is short. As mentioned above. the
dipenylanthracyl radical is then in the singlet excited
state and will fluoresce by returning to the ground state.
The efficiency of this fluorescence is 0.9. This means
that the fluorescence emitted on thermal decomposition
of the dioxetane is now amplified about 180 times via
the fluorescence of the diphenyl-anthracyl radical.
The invention also relates to compounds suitable for
use the preparation of organic compounds according to
the invention labeled with one or more polycyclic aro-
matic groups R1. These compounds have the formula
R1-Y-X, in which R1 represents a polycyclic aromatic
group having at least 3 linearly fused benzene rings,
which group can be excited to a fluorescent state by
energy transfer from a group or compound in a singlet
and/or triplet excited state, Y represents a bivalent
organic radical and X represent a reactive group.
The symbol Y represents abridge radical which,
however, may also be absent when, after reaction with
the organic compound labeled, at least one atom of the
reactive group X remains. That is, the radical R1 should
be separated by at least one atom from the organic
compound to be labeled. Y may be a bivalent hydrocar-
bon radical, such as a methylene, ethylene, propylene,








optionally branched and/or substituted. For example,
Y may also be a bivalent hydrocarbon radical which is
attached to R1 via an oxygen or nitrogen atom or via
an -NH-CO- group.
The reactive group X may be any desirable reactive
group capable of reacting with the organic compound
to be labeled. The following groups may be mentioned
as examples of reactive groups X: hydroxyl and thiol
groups, reactively esterified hydroxyl or thiol groups,
halogen atoms, such as chloro, bromo and iodo atoms,
acidic groups, such carboxyl groups and sulphonic
acid ester groups, oxo groups, acid anhydride groups,
amino groups, cyano groups, isocyanate groups, isothi-
ocyanate groups, thiocyanate groups, amidate groups
or also metal atoms such as sodium or potassium
atoms. The reactive group X may be a magnesium
halide group as well.
Among the reactive carboxylic acid ester groups the
succinylimid-N-yl-oxycarbonyl radical may be men-
tioned. This group, with which good results have been
obtained, reacts readily with compounds containing an
amino group. A reactive group readily reacting with
thiol groups is, for example, the maleinimid-N-yl radi-
cal.
Particularly suitable for labeling proteins containing
one or more free amino groups is the N-hydroxysucci-
nimide ester of 4-(9,10-diphenylanthracen-2-yl)butyric
acid (formula 15).
Further, the invention relates to novel dioxetane
compounds suitable for labeling organic compounds
with a group of formula 1, that is to say one of possible
group  R2. In forumula 2,
A and B represent alkylene radicals which may be at-
tached to each other via an alkylene radical C, and Y'
repres nts a direct bond or a bivalent organic radical.
The bivalent organic radicals Y' include the same radi-
cals mentioned above in the definition of Y. Prefera-
bly, Y' is a bivalent hydrocarbon radical attached to the
radical of formula 1 via an oxygen atom or via the
group -NH-CO-.
A preferred group of compounds of formula 2 has
formula 3.
In formula 3, Y' has the meaning defined above. Com-
pou ds particularly well suited for labeling organic
compounds containing one or more amino groups are
compounds of formula 4
in which n represents an integer of 0-10. Also, good
r sults have been obtained with compounds of formula
5,
in which m represents an integer of 0-10. A preferred














It is also possible to label an organic compound with
both a radical R1 and a radical R2, as defined above, by
using compounds of formula 16, which also belong to
the invention.
In said formula p and q have the value of at least 1, and
X represents a reactive group. The reactive group X
may have one of the above-mentioned meanings, but in
this case X may also represent one or more of the bind-
ing sites of an antigen or an antibody. The symbol Y"
represent a bridge group which is at least trivalent and
which need have no further requirement than that the
groups R1, R2 and X may be attached thereto. An
example of a compound of formula 16 is a compound
of formula 17,
in which R1, R2 and X have the above-mentioned
meanings. The compound of formula 17 may be
prepared by reacting cysteinylglycine (formula 18)
with e.g. R2-CO-Ch2-halogen, which reacts preferen-
tially with the mercapto group, and with R1-CO- alo-
gen or another reactive carboxylic acid derivative of R1
which is capable of reacting with the amino group of
the cysteinylglycine. The carboxyl group of the prod-
uct so labeled with R1 and R2 may then be converted
into a desired more reactive group.
Generally, an important group of compounds of for-
mula 16 may be prepared by introducing one or more
groups R1 and R2 into apolypeptide or protein by reac-
tion with a both a compound of the formula R1-Y-X
and a compound of the formula R2Y'-X. The com-
pounds so obtained may be further modified so as to
make them suitable for reaction with other molecules
which will then be labeled simultaneously with R1 and
R2. Thus, a labeled protein may be attached in a known
way to another protein, to a hormone or to a small
molecule.
The preparation of the compounds of formula R1-Y-
X may be effected by conventional procedures well
known to those skilled in the art, for example, by intro-
ducing the radical- Y-X into a polycyclic aromatic com-
pound R1H. The compound of formula 15 may
be obtained by esterification of the compound of for-
mula 14 with
N-hydroxysuccinimide. The compound of formula 14
has been described already in Ann. de Chimie 4, 479-
539 (1959). According to this publication the com-
pound of formula 14 is prepared from 9,10-diphenyla-
thracene by reacting the latter compound under Frie-
del-Crafts conditions with succinic anhydride in the
presence of aluminum chloride. which results in the
introduction of a succinoyl radical at position 2 of the
diphenylanthracene. Then, the carbonyl radical at-
tached to position 2 of the diphenylanthracene is re-
duced to the methylene group, for example with hy-
drazine or zinc/HCl, to form the compound of formula
14.
The compounds of formula R2-Y'-X may be pre-
pared by conventional procedures, for example by
means of the methods described in Dutch patent
application No. 8201492.
The novel compounds of formula 2, especially the
novel compounds of formula 3 may be prepared, for














The preparation of compounds in which Y' is attache to
the epidioxyadamantyl-adamantyl radical via an oxygen
atom may be effected by reacting the bromide of for-
mula 7 with an alpha,omega-alkylene glycol, which
results in a compound having a hydroxyalkoxy substitu-
ent with a terminal hydroxy group, for example the
compound of formula 8.
The epidioxy group may be introduced into these com-
pounds by conventional procedures using oxygen while
irradiating with light in the presence of methylene blue.
This results, for example, in a compound of formula 9.
-continued
9c: n = 5
The terminal hydroxymethyl radical of this compound
may then be oxidized to form the carboxyl group, for
example with potassium permanganate, to form for
example the compound of formula 10.
The latter compound is then esterified with N-hydrox-
ysuccinimide in the presence of dicyclohexyl carbodi-
imide to form for example an ester of formula 4.
In this connection it is pointed out that, in all cases, a
mixture of isomers is the result of the formation of the
dioxetanes from the corresponding unsaturated com-
pounds, for example adamantylidene-adamantanes.
Each of the isomers and mixtures thereof are suitable
for labeling organic compounds.
Compounds of formula 5 may also be prepared by
using the bromide of formula 7 as a starting material,
by first replacing the bromide atom with an amino
group by reaction with ammonia under pressure. The
amino compound of formula 11
is then acylated with succinic anhydride, and the acyl
compound of formula 12 so obtained is then esterfied
with N-hydroxysuccinimide.
Finally, the ester of formula 13 so obtained is conver-














An example of the compounds of formula 16 is the
compound described in example XIX. The bovine
serum albumin double-conjugate obtained according to
example XIX may be attached to an antibody in a know
way, for example with a water-soluble carbodiimide. In
a similar manner, thyroglobulin was double-conjugated
with the compounds of formula 6, and of formula 15,
respectively, in a molar ratio of 1:100:100. About 50
molecules of each of the labels were attached to the
thyroglobulin. This thyroglobulin-double-conjugate can
be coupled by conventional procedures to a further
protein, for example by
(a) periodate exidation of the sugar radicals of the
thyroglobulin, followed by
(b) condensation with one or more amino groups of a
protein, and finally
(c) by reduction of the condensate with NaBH4.
Antibodies (sheep-anti-human IgG and goat-anti-car-
cinoembryonic antigen (goat-anti-CEA); 2 mg/ml)
were also labeled with R1 and R2 (in 10% dioxane/100
mM borate buffer pH 8.5, 1 hour reaction time) with
various molar ratios of R1 and R2. Sheep-anti-human
IgG immunoglobulin gave a maximum molar labeling
ratio (during the labeling reaction) of 1:15:20 (an-
tibody:R2:R1). In a double-diffusion technique (Ouch-
terlony) a precipitation line with human IgG corre-
sponded qualitatively with that of the unconjugated
sheep-anti-human IgG. Goat-anti-CEA immunoglobu-
lin conjugated wit R1 and R2 (molar ratio during the
reaction 1:20:15) was compared with the same goat-
anti-CEA but conjugated with peroxidase. This was
carried out in a competition experiment in an enzyme-
linked immunosorbent assay (ELISA) technique. It
appeared from this experiment that the double-conju-
gate of g-anti-CEA with R1 and R2 did not show a
strong decrease in immunoreactivity.
Immunoglobulin double-conjugates obtained in the
same way (g-anti-CEA-R1,R2 and s-anti-IgG-R1, R2)
show a specific activity of about 500,000 photon counts
per micorgram (measuring efficiency 0.1%). The maxi-
mum amplification effect by the 9,10-diphenylanthra-
cene radical is not obtained with immunoglobulins be-
cause about 25 R1 radicals per immunoglobulin are
necessary for efficient energy transfer from the excited
adamantanone to this acceptor. This is due to the rela-
tively short so-called critical distance R0. (R0 is ap-
proximately 15 Angstroms according to the theory of
Förster; R0 is the distance between donor and acceptor,
when the efficiency of the energy transfer is 50%).
In view of what is mentioned above it is very
surprising that bovine serum albumin and thyroglobulin
(as examples of a relatively small and a relatively large
protein) can be saturated with R1 and R2, yet remain
soluble in aqueous buffers, and emit a large amount of
light (so-called quantum efficiency of both labels does
not decrease substantially in heavily conjugated prote-
ins). Further it is very important that the compounds
which are labeled with many radicals R1 and 2, are
themselves useful as water-soluble labels.
The process for determination or assay of an organic
compound labeled with one or more polycyclic aromatic
groups R1 having at least three linearly fused benzene
rings, which groups R1 may be excited to a fluorescent
state by energy-transfer from a group or compound in a
singlet and/or triplet excited state, which organic
compound is, optionally, also labeled with one or more
groups R2 which may be excited to a singlet and/or
triplet excited state by thermal energy, is carried out
according to the invention by methods known to those
skilled in the art for effecting qualitative or quantitative
photometry. When a compound containing one or more
groups R1 together with one or more groups R2 is to be
d termined or assayed, the compound has to be heated
so s to excite the group or groups R2 into a singlet
and/or triplet excited state. The groups R2 tran fer their
energy to the groups R1, and this results in fluorescence
of th  groups R1. This fluorescence is measured in the
usual way. In principle, the apparatus consists of an
oven, the temperature of which may be set to a
prede ermined value and in which a sample may be
heated, for example on a plate of glass or of a suitable
plastic, for example polytetrafluoroethylene. A photo-
detector, e.g. a multiplier phototube is positioned as
near as possible to the sample, but separated by a heat
filter. The emitted light may also be transmitted to the
photomultiplier via an optical glass fibre cable. After
i sertion of the sample into the oven the temperature of
the oven is raised to about 250° C. in a few seconds.
The thermal decomposition of the 1,2-dioxetane radicals
will then take place within about 20 seconds. The signal
of e photomultiplier is coupled to a discriminator/pho-
ton-counter via a preamplifier. The discriminator/pho-
ton-counter integrates the signal over a short period of
time, for example 2 seconds. These integrated values are
fed to  computer. The highest integrated value (over 2
seconds) and also the total integrated value (over about
30 seconds) are linearly proportional to the number of
radicals R2 over a very broad range of concentration.
The background signal may be kept extremely low by
removing the oxygen (as far as possible) from the zone
in which the sample is heated, for example by flushing
with nitrogen or by working in vacuum.
The following examples illustrate the invention but




















Ten grams of 4-eq.-bromoadamantylidene-adamantane
of formula 7 was mixed with 250 ml of dry propanediol-
1,3, and the mixture was refluxed for 2.5 hours. The
reaction mixture was poured into 500 ml water.
Extraction with dicloromethane (2 ´ 259 ml), washing of
the combined extracts with 250 ml of water, drying with
MgSO4, filtration and high vacuum evaporation gave
10.0 g of spectroscopically pure 4-eq.-(3--
hydroxypropoxy)adamantylidene-adamantane (formula
8a) in the form of a yellow oil.
Analytically pure material was obtained after distilla-
tion in a rotating evaporator (250° C., 0.002 mm Hg):
9.0 g (91%).
Analysis: calculated for C23H34O2:80.63% C; 10.02%
H. Found: 80.52% C; 9.95%H.






The process of Example I was repeated with the
difference that 250 ml of dry butanediol-1,4 was used
instead of propanediol-1,3. The product, 4-eq.-(4-
hydroxybutoxy)adamanytylidene-adamantane (form ula
8b) was obtained in crude form as a yellow oil (11.0 g),
which was purified by column chromatography on Al2O3
with dichloromethane as the eluent. In this way, 9.94 g
(97%) of spectroscopically pure product was obtained in
the form of a colorless oil.
IR spectrum (neat): 3350 (s), 2900 (s), 1450 (s). 1100
(br) cm-1.
1H-NMR spectrum (CDCl3, TMS): delta 3.8-3.1 (m,
5H); 2,85 (br, 4H); 2.3-1.0 (m, 27H).
13C-NMR spectrum (CDCl3): delta 135.6; 130.8 82.3;
67.5; 62.5; 39.6; 39.4; 39.0; 37.0; 36.8; 35.4; 32.9; 32.2;
31.9; 31.5; 31.0; 30.8; 30.5; 28.3; 27.5; 27.3.
Mass spectrum: M+-peak at m/e 356 (20%); 284; 268;
135; 79.





The process of Example I was repeated with the
difference that 250 ml of dry pentanediol-1,5 was used
instead of propanediol-1,3. The product, 4-eq.-(5-
hydroxypentoxy)adamantylidene-adamantane (formula
8c) which was obtained in crude form as a yellow oil,
was purified by column chromatography on Al2O3 with
dichloromethane as the eluent. In this way 9.0 g (85%)
of a colorless product was obtained.
IR spectrum (neat): 3400 (s), 2900 (s), 1445 (s) 1100
(br) cm-1.
lH-NMR spectrum (CDCl3, TMS): delta 3.8-3.1 (m, 5
H); 2.9 (br, 4 H); 2.45 (s, 1 H); 2.6-1.0 (m, 28 H).
13C-NMR spectrum (CDCl3): delta 135.2; 130.9;
81.7; 67.1; 62.1; 39.3; 38.9; 37.0; 36.7; 35.4; 32.8; 32.1
31.8; 31.5; 30.8; 29.6; 28.2; 27.4; 22.4.
Mass spectrum: M+-peak at m/e 370 (55%); 268; 135;
79.





The compound of formula 8a (4 g) was dissolved in
dichloromethane (700 ml). Methylene blue (20 mg) was
then added. The mixture so obtained was irradiated with
a sodium lamp (Philips SON 160 W), which was
provided with a reflector and was positioned at a short
distance from the solution. During the irradiation, oxy-
gen was led through the solution. The irradiation and
the oxygen treatment were continued for 7 hours, and
solvent was added from time to time. The temperature
of the solution rose to about 40° C. After the irradiation
the solvent was evaporated and the residue was chro-
matographed on a column of Al2O3 with dichlorometh-
ane as the first and ethyl acetate as the second eluent.
The fraction containing the compound of formula 9a
was treated with de colorizing carbon and evaporated.
In this way the compound of formula 9a was obtained
as a mixture of two isomers in the form of a colorless
oil (4.1 g, 94%).
IR spectrum (neat): 3450 (s), 1455 (s), 1100 (br) cm31
.
lH-NMR spectrum (CDCl3, TMS): delta 3.82 (t, J= 11
Hz, 2 H), delta 3.68 (t, J=11 Hz, 2 H); delta 3.15 (br, 1
H), delta 2.85 (br, 1 H), delta 2.65 (br, 4 H), delta 2.3-
1.2 (m, 24 H).
13C-NMR spectrum (CDCl3): delta 96.2; 96.0; 95.4;
77.7; 76.9; 67.5; 67.0; 62.2; 61.9; and 22 peaks between
delta 39 and 25.4.
Mass spectrum: Fragments M=150 and M=224.
Exact mass of largest fragment: expected 224.141;





The compound of formula 8b (9.8 g) was treated as in
Example IV. The compound of formula 9b was ob-
tained as a mixture of two isomers in the form of a
colorless oil (9.4 g; 88%).
IR spectrum (neat): 3400 (s), 2900 (s), 1450 (s), 1100
(br) cm-1.
1H-NMR spectrum (CDCl3, TMS): delta 3.75-3.2 (m,
5 H); delta 3.0-2.4 (m, 5 H); delta 2.3-1.0 (m, 26 H).
13C-NMR spectrum (CDCl3): delta 96.1;95.9; 95.3;
77.3; 76.5; 67.8; 67.6; 62.3; 62.2; and 25 peaks between
delta 36.9 and 25.4.
Mass spectrum: Fragments m/e = 238 and 150
(100%).
Exact mass of largest fragments expected for




















The compound of formula 8c (4 g) was treated as in
Example IV. The compound of formula 9c was obtained
as a mixture of two isomers in the form of a colourless
oil (3.6 g; 83%).
IR spectrum (neat): 3450 (s), 2950 (s), 1460 (s), 1100
(br)cm-1.
1H-NMR spectrum (CDCl3): delta 3.8-3.2 (m, 5 H);
3.0-2.4 (m, with peaks at delta 2.80 and 2.62; 5 H); 2.3-
1.0 (m, 28 H).
13C-NMR spectrum (CDCl3): delta 96.3; 96.0; 95.6;
95.5; 77.2; 76.1; 67.6; 62.6; 62.5; and peaks between
delta 37.3 and 22.3.
Mass spectrum: Fragments at m/e=252 and 150
(100%), further 121 and 79.





propionic acid (formula 10a)
The compound of formula 9a (mixture of two iso-
mers; 0.60 g; 160 mmole) was dissolved in acetic acid
(1.8 cm3). To this solution 0.38 g KMnO4 was added
slowly with stirring at room temperature. After this, the
mixture was stirred for 4 hours at room temperature.
Then, water (50 cm3) and a saturated solution of sodium
hydrogen sulphite in water (20 cm3) were added and the
solution was extracted with 50 cm3 of dichloromethane.
The organic phase was separated, washed with water
(22 ´  50 cm3), dried with magnesium sulphate, filtered
and evaporated. This resulted in a colourless oil. This
was dissolved in pentane/ether 1:2 (50 cm3), and HN3
gas was led through the solution; the compound of
formula 10a precipitated as the ammoniu  salt in the
form of an oil. The supernatant was decanted and the
residue was washed with n-pentane (2 ´ 20 cm3). Di-
chloromethane (50 cm3) was added and the solution was
washed with 2N HCl (20 cm3) and then with water (50
cm3). The solution was then dried with MgSO4 and
filtered. After evaporation of the solvent and drying of
the residue under high vacuum the residue was the
spectroscopically pure compound of formula 10a as a
colourless viscous oil (0.30 g; 48% mixture of two iso-
mers).
IR spectrum (neat): 3700-2400 (s); 2900 (s), 1705 (s),
1460 (m), 1100 (m) cm-1.
1H-NMR spectrum (CDCl3, TMS): delta 9.3 (br, 1 H),
delta 3.75 (t, J=6 Hz, 2 H), delta 3.6 (br, 1 H); 3.0-2.4
(m, 6 H), 2.3-1.0 (m, 22 H).
13C-NMR spectrum (CDCl3). delta 177.2; 96.2;96.0:
95.4; 77.6; 76.6; 62.9; 62.8; and 22 signals between
36.9 and 25.4.
Mass spectrum: Fragments m/e=238 (15%) and 150
(50%), further 222, 165 and 79 (100%).





butyric acid (formula 10b)
The compound of formula 9b (mixture of two iso-
mers; 2.0 g; 5.15 mmole) was oxidized as in Example
VII (acetic acid 5 cm3; KMnO4 1.2 g; reaction time 3
hours), and purified in a similar way. After evaporation
of the dichloromethane the compound of formula 10b
was obtained as a colourless viscous oil (1.58 g; 76%;
mixture of two isomers).
IR spectrum (neat): 3700-2400 (s), 2950 (s), 1705 (s),
1455 (m), 1105 (s) cm-1.
1H-NMR spectrum (CDCl3, TMS): deltas 8.3 (br,
1H), 3.47 (t, J=6 Hz, 2 H), 3.4 (br, 1 H), 2.9-1.0 (m,
with peaks at delta 2.8; 2.6; 2.5; 2.4; 1.85; 30 H).
13C-NMR spectrum (CDCl3): delta 179.3; 96.2; 96.0;
95. ; 77.3; 76.4; 66.6; 66.3; and 23 signals between
37.0 and 25.0.
Mass spectrum: Fragments with m/e=252 and 150
(100%), further 165 and 79.





valeric acid (formula 10c
The compound of formula 9c (mixture of two iso-
mers; 3.6 g; 9.0 mmole) was oxidized as in example
VII (acetic acid 10 cm3; KMnO4 2.0 g; reaction time 3
hours) and purified in the same way. After evaporation
of the dichloromethane the compound of formula 10c
was obtained as a colourless viscous oil (2.4 g; 65%
mixture of two isomers).
IR spectrum (neat): 3600-2500 (s); 2900 (s), 1710 (s),
1460 (m), 1100 (m) cm-1.
1H-NMR spectrum (CDCl3, TMS): delta 9.0 (br, 1 H;
delta 3.6-3.2 (M, 3 H); delta 3.0-1.0 (m, with peaks at
delta 2.78; 2.65; 2.38; 2.28; 1.90; and 1.70; 32 H).
13C-NMR spectrum (CDCl3): delta 1.79.0; 96.4; 96.1;
95.7; 95.5; 77.3; 76.4; 67.2; 40 peaks between 37.2 and
21.6.
Mass spectrum: Fragments with m/e=266 and 150
(70%), further 121, 101, 79.
Exact mass of fragment 266: expected 266.152; found
266.154. No M+-peaks found.
EXAMPLE X
Preparation of the N-hydroxysuccimimide ester of
3-(2,2'-epidioxy-2,2'-adamantyl-adamant-4-eq.-yl-oxy)-
propionic acid (formula 4a)
The compound of formula 10a (mixture of two iso-
mers; 1.85 g; 4.8 mmole) was dissolved in dry dioxane
(10 cm3). Dicyclohexyl carbodiimide (1.1 g; 5 mmole)
and dry N-hydroxysuccimimide (480 mg, 4.85 mmole)
were added to the mixture. The mixture was stirred at
room temperature for 16 hours with exclusion of hu-
midity. The suspension was filtered and the solvent was
evaporated under vacuum. The residue was washed
with dry n-hexane (50 cm3) and then dissolved in dry
dichloromethane (50 cm3). A insoluble portion was
removed by filtration over a short column of sea-sand.
Then the solvent was evaporated under high vacuum.
















form of a white foam (mixture of two isomers; 2.2 g,
95.5; spectroscopically pure).
IR spectrum (neat): 2900 (s), 1810 (m), 1775 (m),
1730 (s), 1460 (m), 1200 (m) cm31 1.
1H-NMR spectrum (CDCl3), TMS): delta 3.83 (t,
J=7 Hz, 2 H); 3.7 (br, 1 H); 3.1-2.4 (m, with peak at
delta 2.85; 10 H); 2.3³1 0 (m, 22 H).
13C-NMR spectrum (CDCl3): delta 168.9; 166.5;
95.9; 95.6; 95.1; 77.6; 62.1; and 19 peaks between
delta 36.7 and 25.1.
Mass spectrum: Fragments m/e=335 and 150, further
165, 149, 121 (100%).
Exact mass of fragment 335: expected 335.137;
found 335.138. No M+-peak.
EXAMPLE XI
Preparation of the N-hydroxysuccinimide ester of
4-(2,2'-epidioxy-2,2'adamantyl-adamant-4-eq.-yl-oxy)-
butyric acid (formula 4b)
The compound of formula 10b (mixture of two iso-
mers; 210 mg.; 0.52 mmole) was esterified with N-
hydroxysuccinimide corresponding to the method of
Example X. After working up as in Example X the
compound of formula 4b was obtained as a residue in
the form of a colorless viscous oil (yield 90%, 235 mg;
spectroscopically pure; mixture of two isomer).
IR spectrum (neat): 2920 (s), 1810 (m), 1780 (m),
1735 (s), 1460 (m), 1200 (m), 1070 (s) cm-1.
1H-NMR spectrum (CDCl3, TMS): delta 3.50 (t, J=6
Hz, 2 H); 3.4 (br, 1 H); 2.80 (s, 4 H); 2.65 (m, 4 H);
2.3-1.0 (m, 26 H).
13C-NMR spectrum (CDCl3): delta 169.0; 168.4;
96.2; 96.0; 95.5; 77.3; 65.7; 65.5; and peaks between
delta 37.0 and 24.5.
Mass spectrum: Fragments m/e=349 (6%) and 150
(35%), further 165. 149, 121 (100%), 79.
Exact mass of fragment 349: expected 349.153;
found 349.152. No M+-peak.
EXAMPLE XII
Preparation of the N-hydroxysuccinimide ester of
5-(2,2'-epidioxy-2,2'-adamantyl-adamant-4-eq.-yl-
oxy)-valerianic acid (formula 4c).
The compound of formula 10c (mixture of two iso-
mers; 2.0 g; 4.8 mmole) was esterified with N-hydrox-
ysuccinimide corresponding to the method of Example
X. After working up as in Example X the compound of
formula 4c was obtained as a residue in the form of a
foamy which substance (95%; 2.35 g; spectroscopical-
ly pure; mixture of two isomers).
IR spectrum (neat): 2900 (s), 1805 (m), 1775 (m),
1730 (s), 1460 (m), 1200 (s), 1060 (s) cm-1.
1H-NMR spectrum (CDCl3): delta 3.50 (t, J = 6 Hz,
2 H); 3.4 (br, 1 H); 2.80 (s, 4 H); 2.65 (m, 4 H); 2.3-
1.0 (m, 28 H).
13C-NMR spectrum (CDCl3): delta 168.9; 168.3;
168.2; 96.1; 95.8; 95.4; 95.3; 77.2; 76.2; 66.9; 66.8;
further peaks between delta 37.0 and 21.5.
Mass spectrum: fragments m/e 363 (5%) and 150
(50%), further 165, 149, 121 (100%), 79.
Exact mass of fragment 363: expected 363.168;
found 363.169. No M+-peak.
EXAMPLE XIII
Preparation of 4-eq.-amino-adamantylidene adamatane
(formula 11)
The compound of formula 7 (7 g, 0.020 mole) was
mixed with dry dioxane (75 ml) in a stainless steel cylin-
der. Then liquid NH3 was introduced (250 ml) until 4/5 of
the cylinder was filled. After cooling the temperature of
the cylinder was raised to 70° C. and kept at that
temperature in a Carius oven. After 3-16 hours the
cylinder was cooled with liquid N2, opened and (after
excess NH3 was evaporated), the contents was poured into
1N NaOH (100 ml). The product was taken up into either
(250 ml), and the ether solution was separated and washed
with H2O (3 ´  200 ml). The organic phase was dried with
MgSO4, filtered and evaporated. The residue was the
c mpound of formula II (spectroscopiclly pure) in the





A solution of the compound of formula 11 (9 g; 32
mmole) in absolute ethanol (75 cm3) was added to a
solution of succinic anhydride (3.2 g; 32 mmole) in
absolute ethanol (150 cm3). The mixture was stirred for
18 hours at room temperature. Then the mixture was
cooled to 0° C. and the product was filtered and washed
with cold ethanol (100 cm3). The compound of formula
12 was obtained as a white solid (12.2 g; 90%); melting
point 253°-256° C).
IR spectrum (KBr): 3400 (m), 3300-2500 (s), 2900 (s),
1720 (s), 1640 (s) and 1550 (s) cm-1.
1H-NMR spectrum (DMSO-d6): delta 7.5 (br. 1 H); 3.6
(m, 1 H); 2.7 (m, 4 H); 2.3 (br, s, 4 H) and resonance t
delta 1.0 (22 H).
13C-NMR spectrum (DMSO-d6): delta 174.0; 170.5;
134.4; 131.5; 53.9; 37.9; 36.7; 35.2; 32.7; 31.7; 31.5;
31.5; 31.4; 30.6; 30.4; 30.2; 29.4; 27.8; 27.0.
Mass spectrum: M+ at m/e 383 (100%), further 365,
283, 266.




amino)-2,2'-adamantylidene adamantane (formula 13)
The compound of formula 12 (1.65 g; 4.3 mmole) was
dissolved in anhydrous dimethylformamide (50 cm3) with
heating. After cooling to room temperature dicy-
clohexylcarbodiimide (900 mg; 4.35 mmole) was added.
After stirring for 10 minutes N-hydroxysuccinimide (660
mg; 5.75 mmole) was added and then the mixture was
stirred at room temperature under exclusion of humidity
during 16 hours. A small amount of precipitate wh ch ws
formed was removed by filtration. The solvent was
evaporated under high vacuum. The residue was washed
with n-hexane (2 ´ 50 cm3) and then dissolved in
dichloromethane (50 cm3). Turbidity of the solution was
removed by filtration through a short column of sea sand.
Then the solvent was removed under high vacuum and the
compound of formula 13 was obtained as a residue in the
form of a white solid (2.06 g, 100%); melting point: 191°-
















IR spectrum (KBr): 3400 (m, NH), 2900 (s), 1805 (m),
1770 (m), 1720(s), 1660(m), 1200 (m), 1060 (m) cm-1.
1H-NMR spectrum (CDCl3, TMS, 200 MHz)): delta
5.95 (d, J=7 Hz; 1 H); 3.9 (m, 3 H); 3.02 (t,J=7.5 Hz; 2
H); 2.87 (m, 4 H); 2.83 (s, 4 H); 2.63 (t, J=7.5 Hz; 2 H);
2.2-1.0 (m, 22 H).
13C-NMR spectrum (CDCl3): delta 168.8; 168.3;
136.0; 130.4; 54.3; 39.4; 39.0; 37.6; 37.1; 35.2; 33.8;
33.2; 32.2; 32.0; 31.6; 31.2; 30.9; 330.6; 28.3; 28.2;
27.3; 26.8; 25.4; 24.7.
Mass spectrum: M+-peak at m/e=480, further 365
(100%) and 267.266.






The compound of formula 13 (800 mg, 1.57 mmole)
was disssolved in dichloromethane (200 cm3) together
with methylene blue (5 mg), and the solution was irradi-
ated and saturated with oxygen in a way described in
Example IV for 5 hours. Decolorizing carbon (200 mg)
was added to the solution; after stirring, the solution was
filtered and the solvent was evaporated under vacuum.
After stirring with n-pentane (50 cm3) and evaporation of
the solvent the compound of formula 5a, a mixture of
two isomers, remained as a white solid (750 mg, 89%).
The material so obtained was spectroscopially pure and
was used as such for coupling reactions.
Melting point 50°-95° C.
IR spectrum (KBr): 3400 (br, NH), 2950 (s), 1810 (m),
1780 (m), 1730 (s), 1650 (m), 1540 (m), 1200 (m), 1080
(m) cm-1.
1H-NMR spectrum (CDCl3, TMS, 200 MHz): delta
6.20 (d, J=8 Hz; ½ H); 6.00 (d, J=8 Hz; ½ H); 4.25 (m,
½ H); 4.16 (m, ½ H); 300 (t, J=8 Hz; 2 H); 2.83 (s, 4 H);
2.65 (t, J=8 Hz); 2.78-2.5 (m, 6 H); 2.2-1.2 (m, 22 H).
13C-NMR spectrum (CDCl3): delta 169.2; 169.1;
168.9; 168.3; 168.2; 96.0; 95.7; 95.4; 95.3; 49.5; 48.6;
signals between 39.4 and 24.7.
Mass spectrum: Fragments m/e 362 and 150; further
247, 219, 149, 100, 79.
Exact mass of fragment 362: expected 362.148; found
362.150.
EXAMPLE XVII
Preparation of N-hydroxysuccinimide ester of
4-(9,10-diphenylanthracen-2-yl)butyric acid (formula
15)
4-(9,10-diphenylanthracen-2-yl)butyric acid of for-
mula 14 (prepared according Ann. de Chimie 4, 479-539
(1959)) was esterified with N-hydroxysuccinimide i  the
way described in Example X. The compound of formula
15 was obtained as an orange-yellow solid (100% yield,
spectroscopically pure), and was used as such for
coupling reactions.
IR spectrum (KBr): 2950 (w), 1805 (m), 1770 (m),
1720 (s), 1620 (m), 1200 (m), 1060 (m). 745 (m), 695
(m) cm-1.
13C-NMR spectrum (CDCl3): delta 168.9; 168.2;
138.9; 137.0; 136.8; 136.2; 131.1; 129.9; 129.7; 129.4;
128.6; 128.2; 127.9; 127.2; 126.7; 126.4; 125.0; 124.8;
124.6; 34.7; 29.9; 25.6; 25.3.
Mass spectrum: M+-peak at m/e=513 (100%), further
497, 416, 399, 356, 343.
Exact mass: expected 513.194; found 513.192.
EXAMPLE XVIII
Coupling of the Compound of Formula 4c to a Protein
d
A solution of the compound of formula 4c (175 mg) in
dioxane (33 cm3) was added to a solution of bovine
serum albumin (1 g) in borate buffer (0.1M; pH 8.5; 133
cm3). After two hours reaction time the clear mixture
was first dialyzed against dioxane (H2O (1:4), (2 dm
3))
and then against distilled water (4 ´ 2 dm3). After
freeze-drying of the protein with BSA was obtained as a
white solid (1 g). This material, which contains about 10
labels per molecule of protein, which was determined by
means of amino group titration according to Habeeb
(Anal. Biochem. 14, 328-36 (1966)) gives 2.106 photon
cou ts per microgram protein in an apparatus for
thermochemiluminescence with measuring efficie cy o
about 0.1 %. The blank value of the measurement is less
than 100 photon counts.
EXAMPLE XIX
A solution of bovine serum albumin-conjugate (0.2
mg) obtained according to Example XVIII, but having a
molar ratio of BSA to the compound of formula 4c of
1:25, in borate buffer (100 mM, pH 8.5; 0.2 cm3) was
mixed with a solution of the compound of formula 15
(0.5 mg) in acetone (0.1 cm3). After 30 minutes reaction
time the conjugate of BSA, compound of formula 4c
and compound of formula 15 was purified by dialysis.
This material, dissolved in a 1% solution of BSA in
distilled water, gives 40 times the number of photon
counts as the starting material used in this example, in
the entire range of concentration (100 pg/ml to 1 m / l;
from this, 1 ml was taken for a measurement).
What is claimed is:
1. A doubly labeled organic compound comprising a
compound to be labeled, a fluorescent label covalently
bonded thereto, said fluorescent label being a polycyclic
aromatic radical R1 having at least three linearly fused
benzene rings, said polycyclic aromatic radical having a
fl orescent electronic excited state to which it can be
excited by energy transfer from another radical having
an electronic excited state, and an excitation label R2
which comprises an organic radical having an electronic
excited state to which it can be excited by absorption of
thermal energy, wherein R1 represents a radical derived
from a compound selected from the group consisting of
rubrene, perylene, 9, 10-dibromo anthracene, 9, 10-
dichloro anthracene and 9, 10-diphenyl anthracene and
wherein R2 represents an organic radical of the formula
which A and B represent alkylene radicals which may
be connected to each other via an optional alkylene
radical C.
2. The labeled compound of claim I wherein said
compound to be labeled is selected from the group
















3. The labeled compound of claim 2 wherein said
protein is an immunoreactive protein.
4. The labeled compound of claim 3 wherein said
protein is an antigen or an antibody.
5. The labeled compound of claim 1 wherein said
labeled compound is an imunological complex.
6. The labeled compound of claim 1, wherein alkyl-
ene radicals A and B each contain 2-5 carbon atoms.
7. The labeled compound of claim 6 wherein said
alkylene radical C contains 1-4 carbon atoms.
8. The labeled compound of claim 1, wherein radical
R2 is the 2,2'-epidiosy-2,2'-adasmantyladamant-4-eq.-yl
radical.
9. A method of detecting a fluorescent labeled or-
ganic compound of claim 1, said method comprising
exciting said polycyclic aromatic radical to its fluores-
cent electronic excited state, whereby it emits fluore-
scece, and detecting the emitted fluorescence.
10. The method of claim 9 wherein said polycyclic
aromatic radical is excited to its fluorescent electronic
excited state by energy transfer from another radical
having an electronic excited state.
11. The method of claim 10 wherein said other
radical is generated by a chemical reaction in the
presence of said labeled organic compound.
12. The method of claim 11 wherein said chemical
reaction is the reaction of an oxalic acid derivative with
hydrogen peroxide.
13. A method of detecting a labeled organic com-
pound of claim 1 comprising heating said compound to
a temperature at which said excitation label R2 is
excited to its electronic excited state by absorption of
thermal energy.
14. A compound of the formula R1-Y-X, in which R1
is a polycyclic aromatic radical having at least three
linearly fused benzene rings, said polycyclic aromatic
radical having a fluorescent electronic state to which it
can be excited by energy transfer from a donor radical
having an electronic excited state, Y represents a direct
bond or a bivalent organic radical, and X represents a
reactive group selected from a succinylimid-N-yl-
oxycarbonyl group or a maleinimid-N-yl group.
15. The compound of claim 14 wherein R1 is the
9,10-diphenylanthracyl group.
16. The compound of claim 14, wherein X represents
an acid halide group.
17. The compound of claim 14, in which X represens
a succinylimid-N-yl-oxycarbonyl group.
18. The compound of claim 14, in which X represents
maleinimid-N-yl-group.
19. The compound of claim 14, in which Y represents
a biavalent hydrocarbon radical.
20. The compound of claim 14, in which Y represents
a bivalent hydrocarbon radical attached to R1 via an
oxygen or nitrogen atom.
21. The compound of claim 14, in which Y represents
a bivaslent hydrocarbon radical attached to R1 via an
-NH-CO- group.
22. The compound of claim 14 which is the N-
hydroxysuccinimide ester of 4-(9,10-diphenylanthrac-
en-2-yl) butyric acid.
23. A compound of the formula
wherein R3 has the formula
wherein A and B represent alkylene radicals, is an op-
tional alkylene radical which may connect A and B, and
Y' represents a direct bond or a bivalent organic radical.
24. The compound of claim 23, wherein said bivalent
organic radical Y' is a bivalent hydrocarbon radical.
25. The compound of claim 23, wherein said bivalent
organic radical Y' is a direct bond or a bivalent hydro-
carbon radical attached to the radical R2 via an oxygen
or nitrogen atom.
26. The compound of claim 23, wherein said bivalent
hydrocarbon radical Y' is attached to the radical R2 via
an -NH-CO- group.
27. The compound of claim 23, wherein Y' has the
formula -NH-CO-CH2-CH2-.
28. The compound of claim 23 having the formula
wherein R3 had the formula
in which Y' is a bivalent organic radical.
29. The compound of claim 28, wherein said bivalent
organic radical Y' is a direct bond or a bivalent hydro-
carbon radical attached to the radical R3 via an oxygen
or nitrogen atom.
30. The compound of claim 28, wherein said bivalent
hydrocarbon radical Y' is attached to the radical R3 via
an -NH-CO- group.
31. The compound of claim 28, wherein Y' has the
formula -NH-CO-CH2-CH2-.








wherein n represents an integer of 0-10.
33. The compound of claim 32 wherein n represents
an integer 2, 3 or 4.
34. A compound of claim 28 haying the formula
wherein m represents an integer of 1-10.
35. A compound of claim 28 having the formula
*   *   *   *   *
